Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN02
- Pharmacological subgroupN02C
- Chemical subgroupN02CA
- Chemical substanceN02CA01Dihydroergotamine
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 8 medicines
- Atzumi5.2MG BASE · powder · Satsuma Pharms
- Dihydroergotamine Mesylate0.5MG/SPRAY · spray, metered · Rubicon Research
- Dihydroergotamine Mesylate1MG/ML · injectable · Sagent Pharms INC
- Brekiya (Autoinjector)1MG/ML · solution · Amneal
Canada
Health Canada · 5 medicines



